Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...

Industry experts in Nigeria’s pharmaceutical sector have urged a renewed focus on domestic drug manufacturing, insisting it ...

Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard ...

Diabetology recently received formal recognition as a distinct physician specialty, which represents a milestone for ...

Dietitian Live has mapped a repeatable subconscious-to-physiology pathway showing that when belief shifts, the body heals. The company uncovered a consistent, client-partnered process for rewiring ...

In a significant development in the high-stakes patent litigation over diabetes blockbuster Semaglutide, the Delhi High Court has refused to grant Danish innovator Novo Nordisk ...

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...

A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger clinical trials. Lowering blood sugar and increasing fat burning – without ...

Resmetirom effectively resolves MASH and improves fibrosis, independent of GLP-1 or SGLT2 inhibitor use, in patients with T2DM. Achieving ≥5% weight loss enhances resmetirom's effects on MASH ...

Health care professionals can have a powerful impact on labeling requirements for drugs by formally petitioning the FDA for ...

Discover the persimmon, a new heart-healthy hero. This bright orange fruit offers sweet flavor and a nutrient boost. Research ...

It’s happening again, isn’t it? Just when we thought we’d moved past the days of 'heroin chic' and ridiculously unrealistic ...